Core Viewpoint - The series of microfilms "Northeast True Action" produced by China Feihe captures the emotional memories of Chinese people through storytelling, emphasizing the themes of perseverance and tradition in the context of Northeast China [1][10]. Group 1: Company Overview - China Feihe has established itself as a leader in the dairy industry by focusing on self-research and production of key nutritional ingredients, significantly reducing reliance on international sources [12][13]. - The company has developed the first domestic production line for lactoferrin, mastering the production of 11 core nutritional ingredients, which strengthens the foundation of nutrition and safety [4][12]. - Feihe's commitment to quality is reflected in its 100% self-controlled farms and its innovative approach to fresh milk processing, setting new industry standards [6][12]. Group 2: Industry Context - The microfilm series illustrates the "stubborn spirit" of Northeast people and enterprises, showcasing how this resilience contributes to the industrial backbone of the nation [3][6]. - Feihe's approach contrasts with the industry trend of adopting light-asset models, as it emphasizes full control over its supply chain from grass to cow, thereby ensuring product quality [6][12]. - The company has been recognized with nominations for the China Quality Award, highlighting its commitment to excellence in the dairy sector [6]. Group 3: Social Impact - Feihe has created 170,000 jobs and increased the income of 160,000 farmers by integrating them into the dairy industry supply chain, demonstrating its commitment to shared prosperity [13]. - The company has donated nearly 850 million yuan to various social welfare initiatives, including education and healthcare, reflecting its dedication to community support [13]. - Feihe's narrative in the microfilms aligns with its mission to enhance national health and well-being, reinforcing its role as a trusted leader in the nutrition sector [9][12].

Group 1 - The 2026 Functional Food Health Summit (FFWS 2026) was held in Bangkok, Thailand, gathering over 150 industry leaders from more than 20 countries to discuss topics such as technological innovation [1] - The summit awarded 10 prizes to Feihe for its outstanding product innovation and research capabilities, making it one of the most awarded companies at the event [1][2] - Feihe's recognition signifies its evolution from a leader in infant formula to a comprehensive provider of all-age nutritional solutions, contributing to healthier and longer lives with "Chinese solutions" [2] Group 2 - Feihe's Vice President and Research Institute Director, Zhang Xuguang, emphasized the company's commitment to unlocking a new era of lifecycle nutrition through market-driven integrated research and development [4] - The company focuses on innovative solutions for different age groups and specific health needs, enhancing its research in basic, functional, and specialized nutrition [4][12] - Feihe's product matrix includes innovations in infant formula, functional ingredients, and specialized foods, showcasing its comprehensive approach to lifecycle nutrition [6][15] Group 3 - Feihe's award-winning products include the "Breast Milk Affinity Formula Technology Innovation Award" and "Outstanding Early Life Nutrition Award," reflecting their alignment with infant physiological needs [8] - The company also received accolades for its liquid milk protein and products launched in Southeast Asia, demonstrating its international technological innovation capabilities [9] - Feihe's advancements in fresh nutrition and its commitment to quality have positioned it as a leader in the global functional food industry [12] Group 4 - Feihe has established a fresh raw material traceability system, enhancing transparency in the supply chain and allowing consumers to verify the origins of ingredients [13] - The company has been a pioneer in the dairy industry, implementing an integrated supply chain model and setting new standards for fresh milk technology [12] - Feihe's lifecycle nutrition strategy encompasses a wide range of products, from infant formula to specialized nutrition for the elderly, ensuring comprehensive health support [15]

Core Insights - The 2026 Functional Food Health Summit (FFWS 2026) held in Bangkok, Thailand, gathered over 150 industry leaders from more than 20 countries to discuss technological innovations in the functional food sector [1][3] - Feihe won a total of 10 awards at the summit, recognizing its outstanding product innovation and research capabilities across various fields, including infant nutrition and functional ingredients [1][3] Group 1: Awards and Recognition - Feihe received recognition as one of the most awarded companies at the summit, highlighting its transition from a leader in infant formula to a comprehensive provider of all-age nutrition [3][10] - The awarded products included Feihe's infant formula and functional foods, which were acknowledged for their scientific solutions to early-life nutrition and health needs [12][18] Group 2: Innovation and Strategy - Feihe's Vice President, Zhang Xuguang, emphasized the company's commitment to unlocking a new era of lifecycle nutrition through market-driven integrated research and development [10][22] - The company has established a comprehensive product matrix that addresses nutritional needs from infancy to old age, showcasing its technological advancements and commitment to quality [27][22] Group 3: Product Highlights - Specific awards included the "Breast Milk Affinity Formula Technology Innovation Award" and the "Active Immune Protein Excellence Product Award," reflecting Feihe's focus on tailored nutrition for different age groups [12][18] - Feihe's liquid milk protein was recognized for its innovative raw material technology, marking it as the only company to receive an award in this category [18][22] Group 4: Future Directions - Feihe plans to continue its focus on lifecycle functional nutrition, leveraging its full supply chain advantages and technological innovations to drive high-quality development in the functional food industry [27][22] - The company has introduced a fresh raw material traceability system, enhancing transparency in the supply chain and ensuring product safety and freshness for consumers [23][22]

Core Viewpoint - Feihe has launched the world's first raw material-level traceability system for infant formula, enhancing transparency and consumer confidence in product safety and freshness [1][3]. Group 1: Product Innovation - The launch of the traceability system coincides with the introduction of two new products, Jicui and Qicui, allowing consumers to trace the production information of key ingredients like whey protein and lactoferrin through a simple mobile scan [1][3]. - Feihe's new products utilize raw materials sourced within 30 days, significantly reducing the freshness measurement from "years" to "days," ensuring nutritional safety and freshness from the source [3][5]. Group 2: Market Insights - According to iResearch, 85% of mothers prioritize "freshness" as one of the top three factors when purchasing infant formula, highlighting the importance of ingredient freshness in product quality [3]. - Industry experts note that the freshness of core ingredients, such as whey protein, which often constitutes over 50% of infant formula, directly impacts the final product's quality [3]. Group 3: Technological Advancements - Feihe employs a leading "fresh extraction active process" to achieve 100% self-sourcing of 11 key ingredients, addressing issues related to long transportation times and nutrient loss associated with imported raw materials [3][4]. - The traceability system allows consumers to verify the freshness of each can of formula, enhancing trust in product quality [4]. Group 4: Clinical Validation - Both Jicui and Qicui have undergone rigorous clinical trials, including RCT (Randomized Controlled Trials), and have received compliance certification from the U.S. FDA, demonstrating their effectiveness in key health indicators [4]. - Clinical results indicate that Jicui closely matches the breastfeeding effect on nine key immune indicators, while Qicui aligns with breastfeeding levels on nine critical brain development indicators [4]. Group 5: Industry Leadership - Feihe's commitment to "new generation more suitable for Chinese babies" reflects its dedication to continuous innovation and setting new standards in the industry, moving from reliance on imported "bulk powder" to fresh milk-to-powder processes [5]. - The introduction of the raw material-level traceability system represents a significant advancement in the industry, showcasing Feihe's ability to define standards rather than merely follow them [5].

Core Viewpoint - Feihe and JD.com have launched two groundbreaking products, Jicui and Qicui, marking a significant innovation in the infant nutrition sector, aimed at meeting the nutritional needs of Chinese babies and leading the industry into a new era of "breast milk-like formula + fresh active technology" [1][3]. Group 1: Product Innovation - The new products focus on "fresh active nutrition," addressing core consumer demands, with 78% of educated mothers prioritizing "active nutrition" and "good absorption" when selecting infant formula [3]. - Feihe's innovation includes the first-ever integration of "fresh raw materials" into the freshness standard of infant formula, creating a closed-loop system from fresh sources to self-produced active ingredients [3][5]. Group 2: Production and Quality - Feihe has achieved self-production capabilities for 11 key raw materials, enhancing freshness by at least 23 times and demonstrating a 6.4 times improvement in absorption [5]. - The products utilize fresh raw materials produced within 30 days, significantly reducing the freshness timeline from years to days, with proprietary extraction techniques ensuring superior quality [5][10]. Group 3: Research and Development - Feihe has established one of China's largest breast milk databases and leads national initiatives in breast milk research, accumulating significant findings that inform product development [8]. - The company holds three leading positions in the industry: first in breast milk research achievements, first in infant formula patents, and first in maternal source nutrition branding [8][10]. Group 4: Clinical Validation - Feihe adheres to a "clinical first, market second" approach, conducting rigorous clinical trials before product launch, ensuring high standards of evidence for the efficacy of Jicui and Qicui [13]. - The clinical trials utilized RCT (randomized controlled trial) designs, achieving compliance with the highest global standards, thus validating the products' nutritional claims [13][16]. Group 5: Nutritional Benefits - Jicui's formula emphasizes a dual-source protective system, enhancing the baby's gut health and immune system, with evidence showing a 10.6% increase in the baby's immunoglobulin sIgA levels [10][17]. - Qicui focuses on brain development, incorporating a unique nutritional structure that mimics breast milk, leading to significant improvements in sleep patterns and cognitive development metrics [12][17]. Group 6: Market Positioning - The launch of Jicui and Qicui represents not just a formula upgrade but a strategic innovation tailored for Chinese infants, setting a new value benchmark in the infant formula industry [17]. - Feihe aims to continue providing products that support scientific nutrition, contributing to the future potential of children and the nation [17].